Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Transplant Cell Ther. 2022 Mar 18;28(6):310–320. doi: 10.1016/j.jtct.2022.03.015

Figure 4. A-D. Day +100 landmark analysis for OS in patients with and without IPS, DAH, COP, and any NPT.

Figure 4

OS = overall survival; IPS = idiopathic pneumonia syndrome; DAH = diffuse alveolar hemorrhage; COP = cryptogenic organizing pneumonia; NPT = non-infectious pulmonary toxicity